144 related articles for article (PubMed ID: 38605893)
1. Activity against
Alkaltham MF; Almansour AI; Arumugam N; Vagolu SK; Tønjum T; Alaqeel SI; Rajaratnam S; Sivaramakrishnan V
RSC Adv; 2024 Apr; 14(17):11604-11613. PubMed ID: 38605893
[TBL] [Abstract][Full Text] [Related]
2.
Dokrungkoon T; Tulyaprawat O; Suwannakarn K; Ngamskulrungroj P
Front Microbiol; 2023; 14():1171861. PubMed ID: 37492259
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA.
Guo H; Seet Q; Denkin S; Parsons L; Zhang Y
J Med Microbiol; 2006 Nov; 55(Pt 11):1527-1531. PubMed ID: 17030912
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial activities of spirooxindolopyrrolidine tethered dicarbonitrile heterocycles against multidrug resistant nosocomial pathogens.
Arumugam N; Almansour AI; Suresh Kumar R
J Infect Public Health; 2021 Dec; 14(12):1810-1814. PubMed ID: 34776342
[TBL] [Abstract][Full Text] [Related]
5. Regio- and diastereoselective synthesis of spiropyrroloquinoxaline grafted indole heterocyclic hybrids and evaluation of their anti-
Arumugam N; Almansour AI; Kumar RS; Mohammad Ali Al-Aizari AJ; Alaqeel SI; Kansız S; Krishna VS; Sriram D; Dege N
RSC Adv; 2020 Jun; 10(40):23522-23531. PubMed ID: 35517328
[TBL] [Abstract][Full Text] [Related]
6. [Characterization of the katG, inhA, ahpC, kasA, and oxyR gene mutations in isoniazid-resistant and susceptible strain of Mycobacterium tuberculosis by automated DNA sequencing].
Chen X; Ma Y; Jin Q; Jiang GL; Li CY; Wang Q
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Apr; 28(4):250-3. PubMed ID: 15854436
[TBL] [Abstract][Full Text] [Related]
7. Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis in Mongolia.
Narmandakh E; Tumenbayar O; Borolzoi T; Erkhembayar B; Boldoo T; Dambaa N; Burneebaatar B; Nymadawa N; Mitarai S; Jav S; Chiang CY
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32312782
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, computational docking and molecular dynamics studies of a new class of spiroquinoxalinopyrrolidine embedded chromanone hybrids as potent anti-cholinesterase agents.
Arumugam N; Darshan V M D; Venketesh V; Pradhan SS; Garg A; Sivaramakrishnan V; Kanchi S; Mahalingam SM
RSC Adv; 2024 Jun; 14(26):18815-18831. PubMed ID: 38867740
[TBL] [Abstract][Full Text] [Related]
9. Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Jagielski T; Bakuła Z; Roeske K; Kamiński M; Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J
J Antimicrob Chemother; 2014 Sep; 69(9):2369-75. PubMed ID: 24855126
[TBL] [Abstract][Full Text] [Related]
10. Variants of katG, inhA and nat genes are not associated with mutations in efflux pump genes (mmpL3 and mmpL7) in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India.
Unissa AN; Dusthackeer VNA; Kumar MP; Nagarajan P; Sukumar S; Kumari VI; Lakshmi AR; Hanna LE
Tuberculosis (Edinb); 2017 Dec; 107():144-148. PubMed ID: 29050763
[TBL] [Abstract][Full Text] [Related]
11. Significance of the coexistence of non-codon 315 katG, inhA, and oxyR-ahpC intergenic gene mutations among isoniazid-resistant and multidrug-resistant isolates of Mycobacterium tuberculosis: a report of novel mutations.
Norouzi F; Moghim S; Farzaneh S; Fazeli H; Salehi M; Nasr Esfahani B
Pathog Glob Health; 2022 Feb; 116(1):22-29. PubMed ID: 34086544
[TBL] [Abstract][Full Text] [Related]
12. The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan.
Tseng ST; Tai CH; Li CR; Lin CF; Shi ZY
J Microbiol Immunol Infect; 2015 Jun; 48(3):249-55. PubMed ID: 24184004
[TBL] [Abstract][Full Text] [Related]
13. Inducing vulnerability to InhA inhibition restores isoniazid susceptibility in drug-resistant
Harrison GA; Wang ER; Cho K; Mreyoud Y; Sarkar S; Almqvist F; Patti GJ; Stallings CL
mBio; 2024 Mar; 15(3):e0296823. PubMed ID: 38294237
[TBL] [Abstract][Full Text] [Related]
14. A virtual screen discovers novel, fragment-sized inhibitors of Mycobacterium tuberculosis InhA.
Perryman AL; Yu W; Wang X; Ekins S; Forli S; Li SG; Freundlich JS; Tonge PJ; Olson AJ
J Chem Inf Model; 2015 Mar; 55(3):645-59. PubMed ID: 25636146
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective synthesis and discovery of novel spirooxindolopyrrolidine engrafted indandione heterocyclic hybrids as antimycobacterial agents.
Arumugam N; Almansour AI; Kumar RS; Siva Krishna V; Sriram D; Dege N
Bioorg Chem; 2021 May; 110():104798. PubMed ID: 33735710
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis.
Rouse DA; Li Z; Bai GH; Morris SL
Antimicrob Agents Chemother; 1995 Nov; 39(11):2472-7. PubMed ID: 8585728
[TBL] [Abstract][Full Text] [Related]
17. Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa.
Kiepiela P; Bishop KS; Smith AN; Roux L; York DF
Tuber Lung Dis; 2000; 80(1):47-56. PubMed ID: 10897383
[TBL] [Abstract][Full Text] [Related]
18. Correlating genetic mutations with isoniazid phenotypic levels of resistance in Mycobacterium tuberculosis isolates from patients with drug-resistant tuberculosis in a high burden setting.
Pinhata JMW; Brandao AP; Mendes FF; Rabello MCDS; Ferrazoli L; de Oliveira RS
Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2551-2561. PubMed ID: 34297229
[TBL] [Abstract][Full Text] [Related]
19. Design of hybrid molecules as antimycobacterial compounds: Synthesis of isoniazid-naphthoquinone derivatives and their activity against susceptible and resistant strains of Mycobacterium tuberculosis.
Reis WJ; Bozzi ÍAO; Ribeiro MF; Halicki PCB; Ferreira LA; Almeida da Silva PE; Ramos DF; de Simone CA; da Silva Júnior EN
Bioorg Med Chem; 2019 Sep; 27(18):4143-4150. PubMed ID: 31378595
[TBL] [Abstract][Full Text] [Related]
20. Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis.
Schaaf HS; Victor TC; Venter A; Brittle W; Jordaan AM; Hesseling AC; Marais BJ; van Helden PD; Donald PR
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1355-9. PubMed ID: 19861006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
